TTrialPathMatch Me to Trials
← Back to trials
RecruitingBrain StrokeStenting TreatmentAcute Ischemic Stroke

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

Eligible age

18–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.

Sponsor: ProMedica Health System

You may qualify if…

  • ✓ 1. 18 to 80 years of age
  • ✓ 2. Presenting with symptoms consistent with AIS
  • ✓ 3. Imaging evidence of an anterior occlusion of the Internal Carotid Artery (ICA) or Middle Cerebral Artery Main Stem (MCA M1), or proximal M2 segment AND residual 70-99% stenosis of the index artery following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling
  • ✓ 4. NIHSS ≥ 6
  • ✓ 5. Ability to randomize within 24 hours of stroke onset.
  • ✓ 6. Pre-stroke mRS score 0-2
  • ✓ 7. Ability to obtain signed informed consent.
  • ✓ 8. ASPECTS Score ≥ 6 by non-contrast CT scan

You may not qualify if…

  • ✕ 1. Females who are pregnant, or those of child-bearing potential with positive urine or serum beta Human Chorionic Gonadotropin (HCG) test
  • ✕ 2. Known severe allergy (more than a rash) to contrast media uncontrolled by medications.
  • ✕ 3. CT evidence of the following conditions:
  • ✕ Midline shift or herniation
  • ✕ Evidence of intracranial hemorrhage
  • ✕ Mass effect with effacement of the ventricles
  • ✕ 4. Acute bilateral strokes
  • ✕ 5. Contraindication to antiplatelet (aspirin, clopidogrel, ticagrelor, cangrelor) or contrast agents

Where it's recruiting

Ohio

Toledo

Source: ClinicalTrials.gov · NCT07356284 · last updated 2026-05-22

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Under · TrialPath